mnnatsop.org

Alzheimer’s disease, which is named after the German born psychologist Alois Alzheimer’s, seems to be an illness of the last century but the brain degeneration, cognitive impairment and worrisome behavioral and psychiatric troubles which characterize the condition have most likely been about for centuries. A short lesson in Alzheimer’s disease history informs us that while Dr. Alzheimer’s is the disease’s namesake, Alzheimer’s friend Emil Kraepelin played an equally valuable part in the recognition of the disease. Kraepelin singled out and grouped together the signs and symptoms of the disorder, suggesting they were a one of a kind disease process, while Alzheimer was the first person to understand what was really happening within the brains of Alzheimer’s patients. He noticed odd plaques and tangles within the brain of one of his subjects, a fifty year old woman who exhibited the symptoms of the disorder revealed by Kraepelin.

After Kraepelin and Alzheimer’s detection of the condition at the beginning of the twentieth century, Alzheimer’s disease history indicates that not many improvements were made in understanding or treating the illness, which could be diagnosed only post-mortem by autopsy until the end of the twentieth century. The illness was first diagnosed in people between the ages of 45 and 65 and described as “presenile dementia”. The name Alzheimer’s disease only came into common use during the 70s and 80s as a label for sufferers over the age of 65. Nowadays the disease has identifiable and diagnosable symptoms that can develop in people as young as 30. As a rule, an aggressive sort of Alzheimer’s disease which occurs in people under the age of 65 has a known genetic component, while the presence of the condition in individuals over 65 has various other factors in regards to its development, like health, profession, and natural environment.

The latest breakthroughs in science have led to a promising new period in the history of Alzheimer’s.  Cognex, the first Food and drug administration approved drug~drug approved by the Food and drug administration} used to slow the disease process became available in 1990 and three similar drugs quickly followed. The medications decrease the speed of cognitive impairment in patients who have mild or moderate Alzheimer’s disease by increasing reduced levels of acetylcholine within the brain, which are vital for the healthy functioning of neurons. More research is being performed into solutions to keep Alzheimer’s disease from developing. Specific hormones such as estrogen and anti-inflammatory drugs like aspirin have been discovered to provide a mediating impact and environmental factors, like mentally demanding work, dancing and mentally stimulating games have been shown to decrease older people’s odds of developing Alzheimer’s disease. Even simple things like putting on a car seatbelt or motorcycle helmet might be important to protecting against Alzheimer’s disease.

Rapid detection methods are being perfected to get better treating the condition. By way of example, genetic research has identified markers for familial Alzheimer’s disease in addition to non-familial Alzheimer’s. Additionally, advanced technologies like PET scans and MRIs, are now being used to discover structural changes in the brain which could possibly reveal the development of Alzheimer’s before symptoms even begin. While the baby boomer generation begins to age, researchers are concerned about the strain which a lot of dementia patients could place upon the healthcare and social welfare systems.

SymptomsOfAlzheimers.org offers answers to a lot of questions that you may well have about Alzheimer’s and is a superb Alzheimer’s resource center for individuals looking after family and loved ones suffering from this ailment.

Alzheimer’s disease, which gets its name from the German born psychologist Alois Alzheimer’s, would seem to be a disease of the last century but the brain degeneration, cognitive impairment and worrisome behavioral and psychiatric complications which usually characterize the condition have undoubtedly been around for centuries. A simple lesson in Alzheimer’s disease history tells us that while Dr. Alzheimer’s is the disease’s namesake, Alzheimer’s friend Emil Kraepelin played an equally valuable part in the identification of the disease. Kraepelin singled out and grouped together the warning signs of the disorder, suggesting they were a unique disease process, while Alzheimer was the first to fully grasp what was truly happening inside the brains of Alzheimer’s sufferers. He identified odd plaques and tangles within the brain of one of his patients, a fifty year old woman who exhibited the symptoms of the disorder identified by Kraepelin.

Following Kraepelin and Alzheimer’s identification of the condition at the beginning of the 20th century, Alzheimer’s disease history shows that few improvements were made in understanding or treating the illness, which could be diagnosed only post-mortem through an autopsy until the last part of the 20th century. The illness was first diagnosed in individuals between the ages of 45 and 65 and tagged as “presenile dementia”. The name Alzheimer’s disease only became popular during the 70s and 80s as a label for patients over the age of 65. These days the disorder has identifiable and diagnosable symptoms that can develop in individuals as young as 30. Frequently, an aggressive form of Alzheimer’s disease that arises in patients under the age of 65 has a known genetic element, while the appearance of the condition in patients over 65 has various other factors in regards to its development, including wellness, job, and natural environment.

New advancements in science and technology have led to a promising new era in the history of Alzheimer’s.  Cognex, the first Food and drug administration approved drug~drug approved by the FDA} used to impede the disease process hit the markets in 1990 and three similar drugs soon followed. The medications decrease the speed of cognitive impairment in individuals suffering from mild or moderate Alzheimer’s by increasing depleted levels of acetylcholine inside the brain, which are vital for the normal functioning of neurons. Similar research is being done into strategies to stop Alzheimer’s disease from developing. A number of hormones such as estrogen and anti-inflammatory drugs such as aspirin have been shown to have a mediating effect and environmental factors, like mentally demanding jobs, dancing and mentally stimulating games have been seen to decrease older people’s odds of developing Alzheimer’s. Even simple things like donning a car seatbelt or motorcycle helmet might be crucial to preventing Alzheimer’s.

Rapid detection methods are being perfected to improve treating the condition. For example, genetic studies has identified genetic markers for familial Alzheimer’s together with non-familial Alzheimer’s. In addition, advanced technology such as MRIs and PET scans, are increasingly being used to find structural changes in the brain which could suggest the development of Alzheimer’s before symptoms even start. As the baby boomer generation starts to age, researchers are afraid of the strain which a large number of dementia patients might place upon the healthcare system.

SymptomsOfAlzheimers.org gives answers to a variety of questions which you will probably have about Alzheimer’s and is the perfect Alzheimer’s resource center for those caring for family and loved ones suffering from this illness.